Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.

Sanghvi CD, Olsen PM, Elix C, Peng SB, Wang D, Chen ZG, Shin DM, Hardcastle KI, MacBeth CE, Eichler JF.

J Inorg Biochem. 2013 Nov;128:68-76. doi: 10.1016/j.jinorgbio.2013.07.014. Epub 2013 Jul 17.

PMID:
23948576
[PubMed - indexed for MEDLINE]
2.

Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.

Matović ZD, Mrkalić E, Bogdanović G, Kojić V, Meetsma A, Jelić R.

J Inorg Biochem. 2013 Apr;121:134-44. doi: 10.1016/j.jinorgbio.2013.01.006. Epub 2013 Jan 16.

PMID:
23376555
[PubMed - indexed for MEDLINE]
3.

Syntheses and crystal structures of tetracopper(II) complexes bridged by asymmetric N,N'-bis(substituted)oxamides: Molecular docking, DNA-binding and in vitro anticancer activity.

Li XJ, Zheng K, Wang LD, Li YT, Wu ZY, Yan CW.

J Inorg Biochem. 2013 Nov;128:97-107. doi: 10.1016/j.jinorgbio.2013.07.027. Epub 2013 Jul 23.

PMID:
23948578
[PubMed - indexed for MEDLINE]
4.

Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.

Maiore L, Cinellu MA, Nobili S, Landini I, Mini E, Gabbiani C, Messori L.

J Inorg Biochem. 2012 Mar;108:123-7. doi: 10.1016/j.jinorgbio.2011.11.007. Epub 2011 Nov 22.

PMID:
22173093
[PubMed - indexed for MEDLINE]
5.

Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.

Pivetta T, Isaia F, Verani G, Cannas C, Serra L, Castellano C, Demartin F, Pilla F, Manca M, Pani A.

J Inorg Biochem. 2012 Sep;114:28-37. doi: 10.1016/j.jinorgbio.2012.04.017. Epub 2012 May 4.

PMID:
22687563
[PubMed - indexed for MEDLINE]
6.

Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex.

Wein AN, Stockhausen AT, Hardcastle KI, Saadein MR, Peng SB, Wang D, Shin DM, Chen ZG, Eichler JF.

J Inorg Biochem. 2011 May;105(5):663-8. doi: 10.1016/j.jinorgbio.2011.01.006. Epub 2011 Jan 22.

PMID:
21450269
[PubMed - indexed for MEDLINE]
7.

Synthesis and characterization of gold(III) complexes possessing 2,9-dialkylphenanthroline ligands: to bind or not to bind?

Hudson ZD, Sanghvi CD, Rhine MA, Ng JJ, Bunge SD, Hardcastle KI, Saadein MR, MacBeth CE, Eichler JF.

Dalton Trans. 2009 Sep 28;(36):7473-80. doi: 10.1039/b823215f. Epub 2009 Jul 21.

PMID:
19727469
[PubMed - indexed for MEDLINE]
8.

Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes.

Yadav A, Janaratne T, Krishnan A, Singhal SS, Yadav S, Dayoub AS, Hawkins DL, Awasthi S, MacDonnell FM.

Mol Cancer Ther. 2013 May;12(5):643-53. doi: 10.1158/1535-7163.MCT-12-1130. Epub 2013 Feb 26.

PMID:
23443803
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of novel pyridine complexes with Zn(II).

Gao EJ, Sun TD, Liu SH, Ma S, Wen Z, Wang Y, Zhu MC, Wang L, Gao XN, Guan F, Guo MJ, Liu FC.

Eur J Med Chem. 2010 Oct;45(10):4531-8. doi: 10.1016/j.ejmech.2010.07.013. Epub 2010 Jul 21.

PMID:
20692739
[PubMed - indexed for MEDLINE]
10.

Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm).

Calamai P, Carotti S, Guerri A, Messori L, Mini E, Orioli P, Speroni GP.

J Inorg Biochem. 1997 May 1;66(2):103-9.

PMID:
9112761
[PubMed - indexed for MEDLINE]
11.

DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects.

Shi P, Jiang Q, Zhao Y, Zhang Y, Lin J, Lin L, Ding J, Guo Z.

J Biol Inorg Chem. 2006 Sep;11(6):745-52. Epub 2006 Jun 9.

PMID:
16763798
[PubMed - indexed for MEDLINE]
12.

Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.

Cattaruzza L, Fregona D, Mongiat M, Ronconi L, Fassina A, Colombatti A, Aldinucci D.

Int J Cancer. 2011 Jan 1;128(1):206-15. doi: 10.1002/ijc.25311.

PMID:
20209498
[PubMed - indexed for MEDLINE]
13.

Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.

Loganathan R, Ramakrishnan S, Suresh E, Riyasdeen A, Akbarsha MA, Palaniandavar M.

Inorg Chem. 2012 May 21;51(10):5512-32. doi: 10.1021/ic2017177. Epub 2012 May 4.

PMID:
22559171
[PubMed - indexed for MEDLINE]
14.

[Zn(phen)(O,N,O)(H2O)] and [Zn(phen)(O,N)(H2O)] with O,N,O is 2,6-dipicolinate and N,O is L-threoninate: synthesis, characterization, and biomedical properties.

Chin LF, Kong SM, Seng HL, Tiong YL, Neo KE, Maah MJ, Khoo AS, Ahmad M, Hor TS, Lee HB, San SL, Chye SM, Ng CH.

J Biol Inorg Chem. 2012 Oct;17(7):1093-105. doi: 10.1007/s00775-012-0923-y. Epub 2012 Jul 24.

PMID:
22825726
[PubMed - indexed for MEDLINE]
15.

[RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.

Tomaz AI, Jakusch T, Morais TS, Marques F, de Almeida RF, Mendes F, Enyedy EA, Santos I, Pessoa JC, Kiss T, Garcia MH.

J Inorg Biochem. 2012 Dec;117:261-9. doi: 10.1016/j.jinorgbio.2012.06.016. Epub 2012 Jul 6.

PMID:
22877927
[PubMed - indexed for MEDLINE]
16.

Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.

Messori L, Abbate F, Marcon G, Orioli P, Fontani M, Mini E, Mazzei T, Carotti S, O'Connell T, Zanello P.

J Med Chem. 2000 Sep 21;43(19):3541-8.

PMID:
11000008
[PubMed - indexed for MEDLINE]
17.

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.

Marcon G, Carotti S, Coronnello M, Messori L, Mini E, Orioli P, Mazzei T, Cinellu MA, Minghetti G.

J Med Chem. 2002 Apr 11;45(8):1672-7.

PMID:
11931621
[PubMed - indexed for MEDLINE]
18.

Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity.

Kaloyanov N, Alexandrova R, Wesselinova DW, Mayer-Figge H, Sheldrick WS, Dimitrov GD.

Eur J Med Chem. 2011 Jun;46(6):1992-6. doi: 10.1016/j.ejmech.2011.02.018. Epub 2011 Mar 3.

PMID:
21474217
[PubMed - indexed for MEDLINE]
19.

Synthesis and structure of new bicopper(II) complexes bridged by N-(2- aminopropyl)-N'-(2-oxidophenyl)oxamide: the effects of terminal ligands on structures, anticancer activities and DNA-binding properties.

Li XW, Zheng YJ, Li YT, Wu ZY, Yan CW.

Eur J Med Chem. 2011 Sep;46(9):3851-7. doi: 10.1016/j.ejmech.2011.05.053. Epub 2011 May 30.

PMID:
21669477
[PubMed - indexed for MEDLINE]
20.

Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study.

Casini A, Kelter G, Gabbiani C, Cinellu MA, Minghetti G, Fregona D, Fiebig HH, Messori L.

J Biol Inorg Chem. 2009 Sep;14(7):1139-49. doi: 10.1007/s00775-009-0558-9. Epub 2009 Jun 20.

PMID:
19543922
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk